← Every lobbying firm
Federal Health Policy Strategies
A registered lobbying firm, and the clients it files for. Everything here comes from the quarterly disclosures it is required to make under the Lobbying Disclosure Act. Filed as FEDERAL HEALTH POLICY STRATEGIES.
Clients
4
named in its filings
Filings
8
2026
Fees reported
$280K
across every filing
Who it represents
Largest first, by what the filings report being paid.
| Client | Fees |
|---|---|
| PfizerPfizer Inc | $120K |
| Fresenius Medical Care North AmericaFresenius Medical Care AG | $120K |
| Scully Roskey And Missmar On Behalf Of Encompass HealthEncompass Health Corp | $40K |
| Abbott Laboratories | — |
Every filing
Newest first, and within a year the largest.
| Client | Fee |
|---|---|
| Pfizer | $60K |
| Fresenius Medical Care North America | $60K |
| Fresenius Medical Care North America | $60K |
| Pfizer | $60K |
| Scully Roskey And Missmar On Behalf Of Encompass Health | $20K |
| Scully Roskey And Missmar On Behalf Of Encompass Health | $20K |
| Abbott Laboratories | — |
| Abbott Laboratories | — |
Source: quarterly LD-2 disclosures filed under the Lobbying Disclosure Act. A fee covers everything the firm did for that client in the period, so it cannot be attributed to any one issue on the list. A filing that states no figure contributes nothing rather than a zero. Clients with no ticker are kept: a trade association or a foreign ministry is as much a part of what the firm does as a listed company.